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Abstract 
Background/Review of Literature: A new cancer diagnosis is overwhelming and stressful.  A 
multitude of information will be shared, and treatment initiated quickly. To prepare patients for 
chemotherapy, a comprehensive and systematic education program should be utilized. 
Combining written instructions and supportive material with nurse-led teaching sessions have 
been found to be most beneficial. Well prepared patients have been shown to have less anxiety, 
more confidence to handle adverse effects at home, and improved quality of life. Purpose: The 
quality improvement (QI) project purpose was to explore the effect of a nurse-delivered, 
enhanced education intervention on distress among older adults receiving chemotherapy in an 
outpatient setting. Design/Methods: The enhanced chemotherapy education intervention 
consisted of a 1-hour educational class facilitated by an oncology nurse, PowerPoint 
presentation, and written materials. A quasi-experimental, pretest-posttest design was used to 
compare outcomes across two groups of patients. Procedures: Group 1 received whatever pre-
chemotherapy educational materials usually offered to patients by the unit (usual care). Group 2 
received enhanced educational intervention prior to their first cycle of treatment. Both groups 
completed a Distress Thermometer and Problem List prior to Cycle 1, and prior to Cycle 2. All 
participants completed an investigator-designed patient satisfaction survey. 
Results/Interpretation: Both groups reported less distress prior to Cycle 2. Group 2 reported 
higher satisfaction scores (100% vs. 89%), called/came to office with fewer concerns (2 vs. 7), 
and fewer Emergency Room and hospital visits (1 vs. 2). The QI project resulted in improved 
patient satisfaction, decreased need for intervention with side effects, and fewer hospital visits 
among adult cancer patients receiving chemotherapy in an outpatient community setting.  
 Keywords: chemotherapy education, distress, quality of life, nurse-led 
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Nurse-delivered Standardized Chemotherapy Education Intervention to Reduce Distress among 
Older Adults in an Outpatient Setting 
A diagnosis of cancer is a life-altering event. Treatment plans are made and patients are 
quickly thrown into a new world of chemotherapy, side effects, and managing complicated 
medications at home (Apor et al., 2018; Garcia, 2014; Mollaoglu & Erdogan, 2014; Sahin & 
Erguney, 2015; Sahin, Erguney, Sahin, & Erguney, 2016; Yuce & Yurtsever, 2017). While 
anxiety can never be completely resolved, it can be reduced through empowering patients and 
their caregivers with relevant evidence-based education and resources. Walking into a chemo 
room for the first time can be emotional and overwhelming for a patient. Education given before 
the first administration of chemotherapy has been shown to reduce this anxiety and lead to better 
quality of life.  
Background 
According to estimates by the American Cancer Society (ACS), over 1.8 million people 
in the United States will be diagnosed with cancer in the year 2020 (ACS, 2019). This represents 
a staggering 4,950 new cases of cancer per day (Siegel, Miller, & Jemal, 2020). Although the 5-
year survival rate for cancer is improving, cancer remains the leading cause of death and is 
expected to rise over the next 10 years to over 23 million worldwide (National Cancer Institute 
[NCI], 2018).  The Centers for Disease Control and Prevention (CDC) estimated in 2018 that 
650,000 patients will receive chemotherapy annually (CDC, 2018).  
Lack of quality educational resources for patients prior to initiating treatment can lead to 
them being poorly equipped to handle side effects and increase their anxiety and distress. In 
accordance with the six quality-dimension initiatives recommended by the Institute of Medicine 
(IOM), a safe and patient-centered approach should be utilized when delivering care (Agency for 
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Healthcare Research and Quality [AHRQ], 2016). Minimum recommendations made by the 
American Society for Clinical Oncology (ASCO) guidelines include providing verbal and 
written education to patients prior to the first treatment. This education should include basic 
medical information, supportive care, contact information, and involve family (Neuss et al., 
2017). 
The problem of incomplete pre-chemotherapy education is significant on a local level as 
not all patients who are scheduled to begin chemotherapy are being provided complete 
educational preparation. Empowering patients with tools to manage adverse effects supports 
competence and when done early in diagnosis can decrease anxiety and stress levels 
(Papadopoulou et al., 2017). Patients who are not provided education using a standardized 
approach can be missing key information regarding the complexities of chemotherapy 
administration.   
Problem Statement 
When newly diagnosed adult cancer patients (>18 years); are not adequately informed 
and prepared to receive chemotherapy treatments prior to the first time they enter the infusion 
center, they often experience more distress and anxiety than they already have. This state can 
lead to increased adverse effects such as nausea, vomiting, and dehydration and is influenced by 
not having had quality, literacy appropriate, and standardized pretreatment chemotherapy 
education. 
Organizational “Gap” Analysis of Project Site  
Lack of education prior to treatment can lead to increased anxiety and side effects, 
ultimately decreasing the quality of life in cancer patients (Apor et al., 2018; Garcia, 2014; 
Mollaoglu & Erdogan, 2014; Sahin & Erguney, 2015; Sahin, Erguney, Sahin, & Erguney, 2016; 
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Yuce & Yurtsever, 2017). Furthermore, standardization of educational processes can lead to 
improved nursing satisfaction, improved efficacy of staff time, and improved quality of care 
(Gallegos et al., 2019). The site used for this QI project is a physician-owned private practice 
located in Central Florida. Permission by the organization was obtained and can be found in 
Appendix A.  At the time of the QI project, this office had seven physicians and eight nurse 
practitioners. There is a large volume of patients each week in the infusion room. Approximately 
300–350 patients per week receive chemotherapy or other intravenous treatments there, and 
approximately ten of those are starting chemotherapy for the first time. The chemotherapy room 
contains 30 chairs. Not all patients were getting education prior to starting chemotherapy; some 
were unsure what to expect or how to manage their side effects. This uncertainty can lead to a 
worsening of common adverse effects such as nausea and vomiting as well as not seeking 
prompt treatment for serious side effects related to neutropenia.   
The charge nurse is responsible to provide a brief verbal educational session. Materials 
are printed by the nursing staff from a variety of online sources and placed in a binder. It was 
difficult to track in a definitive way the number of patients missing the educational class or 
missing key information and resources. Printed materials were not verified by practitioners for 
health literacy or appropriateness.  There was no uniformity for patient education between 
different offices in the practice. The practice’s website had many valuable educational resources 
available; however, there was not one for general prechemotherapy orientation. Over 100 offices 
are part of this practice and, while some locations had been improving on the educational 
processes, there was no uniform policy. When patients and caregivers do not get adequate 
education and knowledge to provide care at home, it can lead to increased anxiety and ineffective 
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care (Garcia, 2014). Therefore, the goal of the QI project was to establish a model that will 
standardize the education program used for all new cancer patients at all locations in the practice.   
Review of the Literature  
Search Methods 
An extensive literature search was completed, including the following databases: Current 
Index to Nursing Allied Health Literature Complete (CINAHL), PubMed, Google Scholar, 
Cochrane Library, and Ovid. All searches were limited to articles during 2013–2019, in the 
English language, peer reviewed, and research articles. CINAHL was searched using the terms 
chemotherapy education or chemotherapy education for newly diagnosed cancer patients or pre-
chemotherapy education or prechemotherapy education. The search was limited to age groups 
19+. This yielded 111 articles with 91 excluded at the title. A total of 20 articles were given 
complete review. One was excluded as it focused on patient beliefs about treatment, one was a 
duplicate of a PubMed article, one was specific to neuropathy, one was excluded for not being a 
pretreatment intervention, one was coping strategies without intervention, one covered chemo 
administration, and finally four were specific to oral chemotherapy. Nine articles were selected 
and included in this review. 
PubMed and Cochrane were searched using Medical Subject Headings (MeSH) terms 
antineoplastic therapy and patient education, excluded for oral chemotherapy. Articles were 
limited to adults. Cochrane yielded zero articles. PubMed yielded 132 articles, 99 were excluded 
at title, 21 were excluded at abstract review, and 12 required full review. Two were excluded for 
small sample size, one was not a study, four were not pretreatment, one was about implanted 
ports, one was specific to drug adherence, and one was a review of older literature. Two articles 
remain included in this review. 
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Google Scholar was searched using terms “prechemotherapy education for patients” 
excluded for term oral, yielded 945 articles. The search terms were narrowed to the phrase 
“chemotherapy education,” yielding 30 articles. Five were included for complete review after 
excluding 25 duplicates from other databases or in this search. One was an abstract of an article 
already included, one was a review, one had small sample sizes, one was specific to goals that 
yielded one article for this review. The Ovid database was searched for keywords chemo* 
education or prechemo* education or pre-chemo* education and patient education yielding four 
articles. Three were excluded for being oral treatments, and one was specific for symptom 
control, leaving zero.   
Search Results 
The 12 articles were appraised using the MeInyk Levels of Evidence (Melnyk & Fineout-
Overholt, 2011). Quality of the evidence was rated using the Johns Hopkins Nursing Evidence-
Based Practice Quality of Evidence Rating Scale (Poe & White, 2010). The 12 articles in this 
review include one randomized controlled trial, six quasi-experimental articles, one integrative 
review, one longitudinal study, and two non-experimental studies. The Appraisal of Guidelines 
for Research and Evaluation (AGREE II; Brouwers et al., 2010) was used for scoring ASCO 
guidelines. A matrix of this data can be found in Appendix B.   
Evidence-Based Interventions 
The evidence supports the use of patient education prior to the first chemotherapy. All 
but one of the 12 studies used education prior to the first chemo. The intervention of a DVD was 
utilized by Milanti, Metsala, and Hannula (2016), which was shown during the actual 
administration of chemotherapy. Several studies used multiple educational sessions with the first 
session prior to the first chemo (Gallegos et al., 2019; Mollaoglu & Erdogan, 2014; Sahin & 
NURSE-DELIVERED STANDARDIZED CHEMOTHERAPY 11 
 
Erguney, 2015; Sahin, Erguney, Sahin, & Erguney, 2016). Furthermore, this recommendation is 
supported in the updated ASCO guidelines in collaboration with the Oncology Nursing Society 
(ONS) as part of the safe administration of chemotherapy (Neuss et al., 2017). All studies 
concluded that education prior to the first chemo was beneficial; however, there was also one 
report of improved quality of life when the education occurred during the chemotherapy (Milanti 
et al., 2016). There was no supporting study that suggested multiple educational sessions are 
better than a single session.   
All studies in which a verbal educational session was used support the use of a nurse as 
the educator. According to Garcia’s review (2014), this is a “consistent theme throughout the 
literature” (p. 520). The role of nurse as educator is described by (Milanti et al., 2016) as one that 
is unique because nurses play an important role in psychosocial interventions. It is further 
suggested by Apor et al. (2018) that even when the oncologist provides some education about 
chemotherapy, they were also discussing diagnosis and prognosis and not focused on specifics of 
treatment. When asked about their knowledge after having met with the oncologist, patients had 
zero or little information about potential adverse effects or scheduling of treatments. One study 
(Gallegos et al., 2019) that was designed slightly differently used one-on-one nurse-led teaching, 
and the group-led class was done by a pharmacist. Nursing implications recommended by 
Papadopoulou et al. (2017) suggest that use of education by nurses can lead to patients’ increased 
perception of self-care strategies and can be expected to reduce anxiety.  
Written education should contain at minimum, goals of treatment, duration, schedule, 
names of drugs and supportive medication, potential interactions, symptoms requiring 
intervention of healthcare provider, self-administered treatments, handling of body secretions, 
follow-up appointment information, and finally pertinent contact information (Neuss et al., 2017, 
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p. 34). There is no definitive recommendation as to which type of educational materials are more 
beneficial than another. In one randomized controlled study, a simple educational handbook led 
to decreased adverse effects (Yuce & Yurtsever, 2017). The evidence does strongly support that 
written content in conjunction with the verbally presented material is superior (Apor et al., 2018; 
Garcia, 2014; Mollaoglu & Erdogan, 2014; Sahin & Erguney, 2015; Sahin et al., 2016). In both 
Keener and Winokur, (2018) and Milanti et al., (2016) additional media are used. Benefits were 
revealed that use of a digitally recorded presentation and a video decreased anxiety and improved 
recall of knowledge (Fee-Schroeder et al., 2013; Keener & Winokur, 2018). The 
recommendation of using audiovisual material was also noted by Papadopoulou et al. (2017). A 
secondary benefit of the standardization process was found by Gallegos et al. (2019) in which 
nurses reported significant improvement in satisfaction. 
Evidence-Based Practice: Verification of Chosen Option  
Based on the literature review, this Quality Improvement (QI) project aimed to provide 
education to all chemotherapy-naïve patients using audio, visual, and written material. The 
program included using an electronic medical record (EMR) to order an educational session, an 
in-person 30–60-minute nurse-led educational group class using verbal and multimedia 
resources, and a handbook/binder of written material (see Appendix C), all provided while 
allowing time for patients and their family to address questions or concerns.   
The patients were asked to use the National Comprehensive Cancer Network (NCCN) 
Distress Thermometer (NCCN, 2018) to evaluate distress levels prior to their first chemo and 
again prior to their Cycle 2 (see Appendix D). The educational material provided was easy-to-
read in plain language that is appropriate for all health literacy levels (Centers for Medicare & 
Medicaid Services [CMS], 2018). The goal of this project was to provide quality education to all 
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prechemotherapy patients to improve quality of life by providing knowledge and decreasing 
distress.   
Theoretical Framework/Evidence-Based Practice Model  
The theoretical framework of Mishel’s Uncertainty in Illness was used to guide the 
project. Mishel’s theory explores the concept of uncertainty when being diagnosed with a new 
illness (Mishel, 1990). Especially in the case of chronic illness such as cancer it is common for 
patients to feel stressed and have difficulty coping. According to Zhang (2017), patients who are 
undergoing cancer treatment have higher reports of uncertainty than those undergoing 
surveillance. Some of the causes for the uncertainty stem from lack of information about their 
disease, not understanding treatment courses, and poor coping with day-to-day tasks (Zhang, 
2017).   
Mishel’s Uncertainty in Illness theory is comprised of four main parts: antecedents 
generating uncertainty, appraisal of uncertainty, coping with uncertainty, and adaptation to 
illness (See Appendix E).  In the first component, new stimuli such as a cancer diagnosis is 
processed by patients according to cognitive coping abilities and support systems. In the second 
component, patients appraise the uncertainty, in this case a cancer diagnosis, which can be 
perceived as a threat or an opportunity that can have a positive outcome. In the coping phase, 
patients use strategies depending on their perception of the diagnosis. These strategies can range 
from seeking information and education, family and emotional support, or other methods of 
coping such as avoidance. In the final phase of Mishel’s theory the patient adapts and adjusts to 
the new illness (Zhang, 2017). 
According to Mishel (1990), uncertainty is highest early in the illness trajectory. This is 
the time when a diagnosis is made, and a patient learns their life has been changed dramatically. 
NURSE-DELIVERED STANDARDIZED CHEMOTHERAPY 14 
 
How the patient copes with their diagnosis and the types of support available will be the 
foundation of how they perceive a new way of life. Support from healthcare providers can be 
beneficial toward promoting integration of the new illness and way of life as one that can be 
adapted to and the instability and uncertainty perceived as natural (Mishel, 1990). Arming the 
patient with information and tools, as done in this QI project, at the time of highest uncertainty is 
likely to be beneficial toward promoting patient autonomy and acceptance. Discussions about 
treatment goals, education in several formats that are literacy-appropriate for patients and their 
family as part of this project aimed to decrease anxiety and distress, thereby improving the 
patient’s quality of life.   
Methods 
Project Design 
The QI project utilized the Plan-Do-Study-Act (PDSA) model. In this model, a test for 
change is made (plan), the test is carried out (do), the results are analyzed (study), and 
improvements and modifications (act) are suggested (Institute for Healthcare Improvement, 
2019). A QI team was created that consisted of a physician, charge nurse, chemo nurses, and the 
assistant office manager. The team’s aim was to facilitate the work planned by the DNP student 
to decrease distress and improve the quality of life for patients prior to starting chemotherapy.  
The DNP student compared quantitative and qualitative data from the pre- and post-intervention 
DT scores. A patient satisfaction survey was provided at the completion of the project, which 
allowed for patient input and suggestions for improvements. This non-validated survey created 
for the project was scored and analyzed by the DNP student. The survey was intended to be brief 
to prevent overwhelming patients with paperwork but still be useful for gathering insight toward 
patient perceptions of the educational experience. 
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Ethical Considerations/Protection of Human Subjects 
The University of Massachusetts, Amherst (UMass) IRB approval was obtained prior to 
initiating the DNP Project. All patients included in the QI project were protected by the Health 
Insurance Portability and Accountability Act of 1996 (HIPAA) in order to protect privacy and 
maintain security of health information (U.S. Department of Health & Human Services, 2017).  
All information collected as part of the project contains no patient identifiers. Confidential 
information was coded using identification numbers. This information has been stored on an 
encrypted, password-protected storage device that was only accessible by the DNP student and 
the charge nurse. IRB approval appears as Appendix F.    
Goals, Objectives, and Expected Outcomes 
The goals for this QI project were aimed to reduce distress by providing education to all 
patients who were scheduled to start chemotherapy as part of their treatment plan. The specific 
intent of the project was to (a) improve the education of all chemotherapy-naïve patients before 
they began treatment, (b) provide education using a brief voice-over PowerPoint presentation, (c) 
provide an in-person nurse-led verbal education session lasting 60 minutes, and (d) provide 
detailed written material for each patient.  Distress was measured using the NCCN Distress 
Thermometer (DT) and Problem List (PL). The scores were totaled and compared pre- and post-
educational intervention. Patient satisfaction (Appendix G) was also measured using a brief 
Likert scale questionnaire.  See Table 1 below. 
Table 1 
Goals, Objectives, Expected Outcomes, and Results of Quality Improvement Project  
Goals Objectives Expected Outcomes Result* 
Improve education of 
chemotherapy-naïve 
All patients will 
receive an order for 
education prior to 
All patients meeting inclusion 
criteria will have education. 
Objective 
Met 
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patients pre-
treatment. 
initiation of first 
chemotherapy. 
Voice-over 
PowerPoint 
presentation. 
Develop brief 8–10-
minute voice-over 
PowerPoint 
presentation that 
includes basic 
overview of 
chemo/infusion 
center by 9/2019. 
100% of patients will be provided 
PowerPoint presentation during 
teaching session. 
Objective 
Not  
Met **  
Provide an in-person 
nurse-led verbal 
education session 
lasting 60 minutes. 
Provide patients with 
verbal education and 
allow question and 
answer time, 
encourage 
family/caregiver 
attendance. 
100% of patients will receive 
verbal education session.  
Objective 
Met 
Provide detailed 
written material for 
each patient. 
Develop written 
binder/folder using 
evidence-based, 
literacy-appropriate 
materials that is 
customizable by 
9/2019.  
100% of patients will receive a 
customized binder/folder prior to 
starting treatment. 
Objective  
Met 
*See results sections, page 22 **See results, page 22 
 
Project Site and Population  
The site for this QI project took place at a private physician-owned hematology and 
oncology practice in the state of Florida. The practice location is one of over 100 in the 
organization. It contains 30 chemotherapy chairs, has seven practicing physicians, and eight 
nurse practitioners. It serves adult patients with all types of cancer. Approximately 10–15 
patients per week start chemotherapy in this practice location, and it was estimated that only 50% 
were receiving formal chemotherapy education by nursing staff. The location of the practice was 
in the town of The Villages, Florida which is a unique, large, and fast-growing age-restricted 
community. As of March 2019, it had a population of approximately 120,000 residents 
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(Straehley, 2019).  The median age is 70 years old with 97% English-speaking and 2% Spanish-
speaking residents (Town Charts, 2017). 
Barriers and Facilitators  
The success of the QI project relied heavily on project stakeholder buy-in. All the 
physicians and nurse practitioners in the practice had to be engaged so that 100% of the eligible 
patients were approached to participate. Providers in this location rotate daily; the DNP student 
provided a detailed overview of the project in writing and on a one-to-one basis with each 
practitioner whenever possible. Internal emails regarding planning and implementation of the 
project were sent to all project team members. The charge nurse was initially met with to discuss 
the project information and plans. Brief weekly meetings were held with the charge nurse to 
discuss patient scheduling and feedback about the project’s implementation and content.   
Involvement of the patients and their significant others was considered the foundation of 
the project. Reduction of anxiety and providing patient-centered care is imperative to quality 
care. Encouragement of family and caregiver support when available is important not only for 
the patients but to allow for questions to be answered. One of the greatest facilitators of the 
project was the desire of all the practice staff to provide quality care that is safe and causes the 
least distress to cancer patients. Barriers to the project included lack of buy-in by staff and 
physicians, which mostly occurred due to time constraints, scheduling, and workload. Patients 
can often start treatment just days after being diagnosed. This leads to urgency in starting 
treatment. In those rare cases, patients were scheduled outside of the regular education session 
and were provided education on a one-to-one basis. 
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Cost-Benefit Budget Analysis 
The costs for this QI project were minimal. The previous method for providing patient 
education was to print material in the office and place it in a folder.  It is difficult to estimate 
what the previous costs were as materials were part of the office supplies. Costs incurred for this 
project included printing the educational handbook created by the DNP student.  No additional 
staff salary costs for this project were required as the charge nurse was met with during normal 
working hours.  The verified neutrality of costs highlights the ability for this project to be 
considered a sustainable intervention. A total breakdown of costs can be found in Appendix H. 
Implementation: Overview 
A homogenous sample was maintained for the project by excluding patients scheduled to 
receive other agents such as immune therapy or oral agents. The term chemotherapy for use in 
this QI project included all intravenously delivered anti-neoplastic chemotherapy agents. The 
patients were divided into two groups.  Implementation of the project began with patients in 
Group 1 who were given no intervention. This group received the standard of practice for 
education which varied from education provided by their physician, education provided by 
nursing staff just prior to chemo, or a group led education provided by the charge nurse. Patients 
in Group 2, the enhanced education group, were scheduled for Patient Education as part of 
discussions with their physician about treatment plans. When chemotherapy orders were placed 
in the EMR, the option to choose Patient Education was made. At the end of each appointment, 
patients were taken to the checkout desk, where tests, follow-ups, and chemotherapy infusions 
were scheduled as part of usual procedures. The checkout staff were notified of the DNP 
student’s QI project to ensure that all patients scheduled for their first chemotherapy had ordered 
Patient Education and the time was scheduled appropriately.  
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The charge nurse populated a list of patients at the end of each week to prepare for 
chemotherapy medication ordering. This list also identified which patients were eligible to 
participate in the DNP project. A conference room large enough to hold patients and their 
significant others was reserved for the once weekly verbal educational session led by the charge 
nurse and DNP student. This was done on Friday afternoons in order to provide the enhanced 
education to any patient scheduled to start chemotherapy the following week. Upon completion 
of the 60-minute session, which began with a PowerPoint presentation, the patients were given 
written handout material. Time was allowed by the DNP student and charge nurse for review of 
the material and for any additional questions. The verbal session/PowerPoint included general 
information about the infusions center, pharmacologic information, and common issues 
experienced by patients receiving chemotherapy.  
Based on observations made by the DNP student and the charge nurse, it was decided to 
stop using the PowerPoint presentation after the first two enhanced education sessions. Patients 
were noted to be focused on the slides and where to find the information on the slides in their 
handouts. Once the PowerPoint was eliminated, patients were given a personalized education 
handbook that was verbally reviewed page by page. 
Measurement Instruments  
In order to measure the outcomes of this DNP Project the following instruments were 
used: NCCN Distress Thermometer and Problem List (NCCN, 2018) as well as a Patient Survey 
developed by the DNP student.  The DT instrument consists of a simple scale 0 (no distress)–10 
(extreme distress). The PL portion of the Distress Thermometer has yes and no questions related 
to five different categories of common emotional and physical issues. This tool is useful for 
screening distress and has been validated for different types of cancer, in various settings, and in 
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multiple countries (NCCN, 2018). A meta-analysis (Ma et al., 2014) of 42 studies found, when a 
cutoff score of 4 is used, a pooled sensitivity of DT to be at 81% (95% CI, 0.79–0.82) and the 
pooled specificity to be 72% (95% CI, 0.71–0.72). The PL section of the tool was created by the 
NCCN Distress Management Panel and has been validated by two studies (Graves et al., 2006; 
Tuinman, Gazendam-Donofrio, & Hoekstra-Weebers, 2008). The PL is beneficial as a general 
baseline needs assessment. The patient survey tool is brief, consisting of four Likert-scaled 
questions (5 highest, 1 lowest), two yes or no questions, and a place to provide written 
comments. 
Data Collection Procedures  
Data collection began with the first group of patients by reviewing the EMR for patients 
who were planned to start Cycle 1 on Day 1 of their chemotherapy. This was done with 
assistance of the charge nurse. Patients were approached during the start of their chemotherapy 
while in the infusion room. The DNP project was discussed with each patient, a consent form 
was completed, and a signed copy returned to the patient. Each patient was provided the NCCN 
DT and PL. A spreadsheet was created to record patient medical record numbers, the date of 
Cycle 1 Day 1 and the date they would start Cycle 2 Day 1. The first group of patients were 
chosen to participate without any intervention in the usual educational processes or changes in 
current procedure; it was recorded if they received any formal chemotherapy education or not.  
Each patient included in the project on Cycle 2 Day 1 was approached while in the chemo room. 
They were asked to complete the DT and PL a second time and were given the patient survey 
form to complete. Scores from the patient survey were recorded as well as any written comments 
made by patients. All data was recorded into an Excel spreadsheet, including patient 
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demographics. All de-identified data was kept in the locked file accessible only to the DNP 
student and the charge nurse.  
Data collection for Group 2 patients was done in similar format. Patients planned to start 
chemotherapy were located by searching the EMR and discussions with the charge nurse. The 
patients were each scheduled for the enhanced chemotherapy education class through the Patient 
Education order in the EMR. The patients were approached about the DNP project at the 
beginning of the class. They were each provided the DT and PL, along with the consent form and 
the patient education handbook created by the DNP student. It was later determined, based on 
observations, to not distribute the DT and PL at the education class because patients were 
overwhelmed with paperwork during the class. Instead of at the class, patients were given the 
paperwork on Cycle 1 Day 1 of their chemo while in the infusion room. Data was collected and 
privacy maintained as done with Group 1 patients. Handwritten comments on patient surveys 
were also recorded and arranged in a table.    
Data Analysis  
The de-identified data of Group 1 and Group 2 patients included both pre-and post-DT 
and PL, the patient survey, handwritten comments, and demographic data. This information was 
used to create an Excel spreadsheet. The thermometer score from the DT was recorded as 
numerical value 0–10. The 39 questions of the PL were recorded as “Y” or “N.” The results of 
the Likert scale patient survey were recorded numerically 1–5. A final column was created to 
record handwritten comments. The spreadsheet was used by the DNP student to analyze pre-and 
post-scores of Group 1 and Group 2 patients.   
At completion of data collection, the results were entered into the Statistical Package for 
Social Sciences (SPSS) and coded appropriately for analysis. Descriptive statistics were used to 
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report demographic characteristics (see Table 2), PL and patient satisfaction scores. Ratio-level 
data from the pre- and post-DT were analyzed using paired sample t-tests for each group and 
independent sample t-test for between-group comparisons. The frequency of individual items 
reported on the PL can be seen in Table 3. Qualitative data was collected and recorded from 
handwritten comments on the patient satisfaction survey (see Table 4). Additionally, patient 
satisfaction scores were compared along with the number of calls to the nurse triage line/visits to 
office, and number of visits to ER and presented in table format. 
Results 
Demographics 
Non-Intervention Group 
Group 1 of the QI project originally contained 21 patients, yet unfortunately one patient 
died prior to post-testing, leaving (n = 20). A second patient declined participating in the post-
data collection and was therefore excluded from analysis, with remaining total participants (n = 
19). The average age of Group 1 participants was 73.21 years with the minimum age of 43 and 
maximum age of 85. Fifty-eight percent of participants were male (n = 11), while females in 
Group 1 accounted for 42% (n = 8). A variety of cancer types were found among the 
participants, with the most common cancer diagnosis being lung cancer 15.8% (n = 3). Advanced 
stage cancer was found to be the most common; stage IV cancer, which included stage IVA, and 
IVB, was the most common at 63.2% (n = 12). A total of (n = 8) patients in this baseline group 
attended a group setting educational class given by the charge nurse with the usual standard 
procedure for education, and a total (n = 11) had some other type of education such as one-on-
one with the RN in the infusion room just prior to administration of chemo. 
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Intervention Group 
Nineteen patients agreed to participate in Group 2 of the DNP project and receive the enhanced 
educational session that was created for the DNP project. The average age in this group was 71 
years old with a minimum age of 52 and maximum of 87 years. Most participants in Group 2 
were female 52.6% (n = 10). The most common type of cancer in Group 2 was breast 26.3% (n = 
5). Twenty-six percent (n = 5) had advanced Stage IV cancers.   
Table 2 
Participant Demographics 
 Group 1 
N = 19 
Group 2 
N = 19 
Patient Characteristics n %* n %* 
Age (years) 
  40–50 
  51–60 
  61–70 
  71–80 
  81–90 
 
1 
2 
1 
10 
6 
 
5 
10 
5 
50 
30 
 
2 
6 
8 
3 
 
10 
32 
42 
16 
Gender 
  Male 
  Female 
 
11 
8 
 
60 
40 
 
9 
10 
 
47 
53 
Cancer Type 
  Breast 
  Colon 
  Diffuse Large B-Cell 
Lymphoma 
  Head & Neck  
  Lung 
  Lymphoma – other  
  MDS 
 Melanoma 
 Multiple Myeloma 
 Neuroendocrine 
 Gyn (Ovarian/Cervical)  
 Pancreatic 
 Prostate 
 Rectal 
 Other 
 
1 
1 
2 
2 
3 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
 
5 
5 
10 
10 
15 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
 
5 
1 
1 
1 
4 
1 
1 
 
1 
 
1 
1 
 
 
2 
 
 
26 
5 
5 
5 
21 
5 
5 
 
5 
 
5 
5 
 
 
11 
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Cancer Stage  
  Missing 
  Extensive 
  High Risk 
  I 
  II 
  III 
  IV 
  Low Risk  
 
3 
1 
1 
1 
 
3 
10 
1 
 
15 
5 
5 
5 
 
15 
50 
5 
 
 
2 
 
 
3 
5 
3 
5 
 
 
 
11 
 
 
16 
26 
16 
26 
*Rounded to nearest whole number. 
Distress Thermometer  
Group 1 vs. Group 2 Post-Distress Thermometer Comparisons 
Group 1 (no-education intervention group) was compared to Group 2 (who received the 
enhanced DNP project educational intervention). Post-DT scores were compared between the 
two groups. The DT instrument is measured as 0 (no distress)–10 (extreme distress). The lower 
the number a patient chose indicates they felt less distress. A higher number indicates more 
perceived distress. Results were Group 1 (M = 3.00, SD = 2.65), and Group 2 (M =  2.21, SD = 
2.72). An independent samples t-test indicated there was no statistically significant difference in 
the post-DT scores of Group 1 when compared with Group 2, t(36) = .907, p = .814. 
Group 1 Pre- and Post-Distress Thermometer Score Comparisons 
The scores of Group 1 participants were compared pre- and post-start of chemotherapy 
using paired samples t-test. The results showed that patients had higher scores before the 
educational session (M = 4.95, SD = 2.80) than they did after receiving the educational session 
(M = 3.00, SD = 2.65). The difference found was 1.95 points between the pre-DT scores and the 
post-DT scores. A paired samples t-test found this difference to be significant, t(18) = 2.787, p = 
0.012. 
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Group 2 Pre- and Post-Distress Thermometer Score Comparisons 
A comparison was made within Group 2, those who received the DNP project enhanced 
educational intervention. The DT scores were compared pre- and post-chemotherapy. The pre-
DT scores were compared  with the post-DT scores. The results showed that patients had higher 
distress scores before the educational session (M = 4.95, SD = 3.36) than they did after receiving 
the educational session (M = 2.21, SD = 2.72). The difference found was 2.74 points between the 
pre-DT scores and the post-DT scores. A paired samples t-test found this difference to be 
significant, t(18) = 3.311, p = 0.004 (see Figure 1). 
Figure 1  
Distress Thermometer Scores for Both Groups.  
 
Problem List 
The PL contains 39 yes/no questions. Each group was provided the PL before Cycle 1 of 
chemotherapy and a second time before Cycle 2. The “Emotional Problem” section of the 
problem list contains seven items: depression, fears, nervousness, sadness, worry, loss of interest 
in usual activities, and spiritual/religious concerns. When comparing frequency data, both groups 
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reported yes more often in the pre-test than in the post-test to all questions except in one. Loss of 
interest in usual activities had an additional yes answer in the Group 2 post-test.  
The Physical Problems section contains 22 items. The most frequently reported symptom 
in both Group 1 and Group 2 was fatigue. This number increased in Group 1 from 52.6% to 
78.9% and in Group 2 it remained constant at 47.4%. Sleep was the 2nd most reported problem in 
Group 1 and remained constant in both pre- and post-testing. The second most common problem 
in Group 2 was eating (26.3%) both pre- and post-testing and sleep, which increased in the post-
test by 5.3%.  
Table 3 
Problem List Frequency 
 Group 1 Group 2 
 Pre- Post- Pre- Post- 
Child Care 
Housing 
Insurance 
Transportation 
Work/school 
Treatment decisions 
0 
0 
3 
1 
0 
5 
1 
0 
1 
1 
2 
1 
0 
2 
6 
1 
1 
5 
0 
1 
2 
2 
1 
1 
Dealing with children 
Dealing with partner 
Ability to have children 
Family health issues 
1 
1 
0 
2 
1 
0 
0 
2 
0 
3 
0 
2 
0 
2 
0 
0 
Depression 
Fears 
Nervousness 
Sadness  
Worry 
Loss of interest 
Spiritual/religious 
2 
7 
9 
4 
10 
3 
0 
2 
4 
5 
4 
6 
5 
0 
4 
4 
10 
6 
9 
4 
1 
3 
3 
7 
2 
5 
5 
0 
Appearance  
Bathing/dressing 
Breathing 
Changes in urination 
Constipation 
Diarrhea 
Eating 
2 
1 
2 
4 
7 
0 
1 
2 
1 
4 
1 
5 
3 
4 
4 
2 
2 
3 
2 
3 
5 
5 
3 
2 
1 
8 
5 
5 
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Fatigue 
Feeling swollen 
Fevers 
Getting around 
Indigestion 
Memory/concentration 
Mouth sores 
Nausea 
Nose dry/congested 
Pain 
Sexual 
Skin dry/itchy 
Sleep 
Substance use 
Tingling hands/feet 
10 
4 
1 
1 
4 
2 
1 
2 
2 
6 
2 
5 
7 
0 
2 
15 
4 
0 
4 
5 
6 
2 
6 
3 
4 
3 
6 
7 
0 
5 
9 
2 
2 
4 
3 
3 
2 
1 
2 
4 
0 
2 
5 
0 
2 
9 
1 
3 
4 
4 
4 
5 
6 
3 
1 
0 
6 
6 
0 
4 
 
Patient Satisfaction Survey 
Comparison of Group 1 vs. Group 2 total patient satisfaction scores shows patients in 
Group 2 reported higher satisfaction 16.89 and 19.00 respectively. All patients in Group 2 
reported the highest score possible of 5 points. There were seven calls to nurse triage line or 
visits to office in Group 1 compared with four for Group 2. Patients in Group 1 went to the ED 
or urgent care more (n = 2) than in Group 2 (n = 1).  
Table 4 
Satisfaction scores and emergency calls/visits 
 Group 1 Group 2 
Satisfaction Score M = 16.89, SD = 4.665 M = 19.00, SD = 1.826 
Called Nurse Triage Line n = 7 n = 4 
Went to ED/Urgent Care n = 2 n = 1 
 
Patient Survey Comments 
 Each individual comment written on the patient survey instrument is presented verbatim, 
and in their entirety, below in Table 5. 
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Table 5 
Patient survey comments 
Patient Satisfaction Comments 
Group 1 
Patient Satisfaction Comments 
Group 2 
Nurses are very helpful. 
Issues with constipation. 
Too educational. 
Everything well organized. Nurses very 
attentive. 
Immune therapy should be separate from 
chemo. 
Nurses very helpful. 
Patient declined “Very upset I did not go to a 
class” 
 
The class was excellent and extremely 
informative. 
All concerns were answered. 
Handouts were great 
Pleasure to go. 
Learned so much with the questions and 
answers. 
Class extremely helpful. 
Everything has been good. 
I feel very informed. 
 
Interpretation/Discussion 
The enhanced education program was created based on observations made for a need to 
improve standard operating procedures in a large oncology practice in order to reduce anxiety 
and distress to cancer patients.  There was one patient in Group 1 who completed the pre- 
information but was upset she did not receive group education and declined to complete any 
further information. The patients who participated in the group program were receptive to 
receiving education and scheduling the session prior to starting chemo. Many patients brought 
families and caregivers, which was reported to be helpful. It was noted during the question-and-
answer portion of the session that, when a patient asked a question, it was often followed by 
other patients and family members asking questions. The group setting made for a comfortable 
environment where patients could feel safe and not rushed.   
It is important to discuss that all patients received some type of pre-chemotherapy 
education as it would be unethical to have a no-education group vs. an education group. Another 
important observation made regarding higher scores in the pre- and post-scores of both groups is 
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that patients are likely less distressed when starting Cycle 2 of chemotherapy because they had 
some familiarity with the process and known expectations. Many may have also had a follow-up 
appointment with their physician or nurse practitioner and had an opportunity to discuss 
concerns.   
Results of the patient satisfactory survey indicated higher satisfaction among those in the 
enhanced education group. Questions 5 and 6 of the survey “Did you call the triage nurse or 
come to the office with a concern about your treatment” and “Did you visit the Emergency 
Department, Urgent Care or Hospital for an emergent issue regarding your treatment” indicate 
that patients who received the enhanced educational session called or came to the office less than 
the group that did not receive this session (36.84% vs. 21.05%). Seven patients in Group 1 either 
called the nurse triage or visited the office due to adverse effects; of those, six did not attend any 
group educational session The two patients who did visit the Emergency Room, Urgent Care, or 
Hospital had not attended any group education. This may indicate that while patients still have 
similar side effects from chemotherapy, as noted in the PL, when they are provided with 
education, they are better equipped to handle them at home requiring less intervention.  
The cost for treatment of dehydration and/or nausea is approximately $330 per patient. 
Fewer calls to nurse triage and visits to the infusion center for hydration, anti-emetics, and other 
treatments reduces costs.  This includes reduced chair time in the clinic, nursing services, and 
supplies.  Providing education can be billed under level 1 office visit, for which the fee is 
approximately $53.00.  The amount collected by insurance varies, e.g. Medicare is $21.20.  This 
fee is enough to pay for the cost of materials.  Education did not eliminate all potential side 
effects or need for patients to come to the clinic when appropriate; however, the number of 
occurrences were reduced through improvement of patient self-efficacy. 
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While some of the providers of the practice were not immediately receptive to the change 
in usual practices, the majority did participate by sending their patients to the enhanced 
education session. The charge nurse, who is responsible for patient education going forward, has 
adopted this new enhanced educational technique and is using the handbook created for the 
project. A second office location has also started using the handbook in their office. Ongoing 
discussion among the physician partners is to now implement a standardized education session 
for all chemotherapy patients on a regional level. While statistical significance was not met 
between the means of Group 1 and Group 2 post-test scores in this project, the impact in 
changing the customary procedure to a program that supports best practice as seen in the 
literature will prove beneficial to patients.   
Theoretical Outcomes 
The theoretical approach to this DNP QI project, Mishel’s Uncertainty in Illness provided 
a valuable framework. Throughout the implementation and analysis of the project, application of 
the theory was found to be relevant. A patient’s perception of a chronic illness can be improved 
using positive coping resources such as education. Reducing confusion and disorganization early 
in the trajectory of cancer treatment can assist patients’ outlook on their condition (Zhang, 2017). 
As found in the patient satisfaction survey and comments, those in the enhanced education group 
reported a higher level of satisfaction. It’s possible that the tools used for measurement in this QI 
project were not precise enough in the capturing of anxiety levels related to anticipation of 
chemotherapy and how education directly reduced those levels. While uncertainty cannot be 
eliminated, continued efforts to provide a base of knowledge early in the treatment trajectory can 
allow for better coping and fluidity with change. A patient’s ability to adapt can be improved. 
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Uncertainty and change can be viewed as something still within their control instead of leading 
to feelings of danger and helplessness (Mishel, 1990).   
Implications for Nursing 
A theme noted among all the patients that participated in the project is the value of 
nursing care and the consensus that they were listened to and felt comfortable asking questions.  
When education was performed in the group enhanced education session verbal comments were 
in praise of how much the class helped and that they really enjoyed attending.  Though the 
sample size was small in each group fewer calls to nurse triage and visits for urgent care show 
that empowerment through education equips patients with tools needed for side effect 
management. This project did not include a nurse satisfaction survey; however, nurses did 
verbally recognize they appreciated that patients who attended a dedicated group education 
session were more prepared to start chemo when they came to the infusion center for the first 
time. Patient that have advanced preparation are better equipped to handle expectations on their 
first day. Standardizing and improving patient education ads value by providing nursing staff 
with preprinted, evidence-based resources. This eliminated time nurses would need to spend on 
locating and printing materials and put less pressure on chemo nurses who carry heavy 
workloads on a daily basis. The nurses reported that patients who were well prepared also had 
less anxiety and nervousness. Patients had the chance to review educational material at home and 
come to chemo with specific questions and concerns instead of starting the education process 
from the beginning.   
Conclusion 
Anxiety is a common reaction when a patient learns they have cancer and will be starting 
chemotherapy. Providing patients with a structured educational toolkit that provides both a 
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verbal session where questions can be addressed as well as written material that can be 
referenced at home can help to reduce the level of anxiety. The PowerPoint presentation was 
found to be distracting during the enhanced educational session; however, it may be beneficial if 
made available upon request electronically or linked on the practice website, thus allowing 
patients and caregivers to view it at home as an additional resource. Providing patients with 
appropriate resources about their self-care and potential adverse effects of treatment can 
potentially lower the severity of adverse effects, allow patients to treat common symptoms at 
home, and reduce the number of emergency visits to the clinic they will need to make.  
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Appendix B 
Literature Review Reference Matrix  
 
Author/ 
Design 
Grade/Level of 
Evidence 
Hypothesis n = Setting Methods/ Measures Data Analysis Outcomes/Results Strengths 
Weaknesses 
1.  Apor et al. 
(2018) 
Non-
experimental 
Level III 
Quality B 
In preparation of 
chemo, understand-
ing potential side 
effects, goals, 
treatment schedule, 
contact info will 
reduce stress and 
anxiety, leading to 
better compliance, 
quality of life, 
better outcomes  
n = 196 
 
 
Survey developed to assess 
effect of specific 
chemotherapy educational 
curriculum 
Structured nurse-led 
chemotherapy educational 
session 60–90 minutes, 
family/support encouraged 
to attend 
+ handout given  
1st Survey presented  
before teaching 
appointment;  
2nd survey before Cycle 1 -  
3rd survey before Cycle 2 
Analyses performed 
with SAS software  
 
Ordinal value for 
multinomial 
distribution 
generalized linear 
model to model 
random effects 
analyzing results 
across time  
Significant 
increases observed 
in perceived 
knowledge of 
treatment schedule, 
potential side 
effects, and use of 
meds to prevent 
nausea 
 
Reduced 
generalized anxiety 
about treatment (p = 
0.0294).  
Completely 
understand how to 
take nausea 
medicine, n = 26 
survey 1 vs. n = 130 
survey 3 (p < 
0.0001) 
Conclusion: nurse 
led chemo after 
initial physician 
discussion but prior 
to starting chemo 
improves patients 
S:   
Data analyzed after 
one educational 
session  
Discussed that n = 
52 patients had no 
perceived 
knowledge after 
meeting with dr 
only and n = 52 had 
minimal 
information about 
treatment side 
effects  
 
W:  
Developed own tool 
by the Brown 
University 
Oncology Research 
Group (BrUOG) = 
developed by 
investigators & 
reviewed by focus 
group of practicing 
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perceived 
knowledge of 
treatment schedules, 
anticipated adverse 
effects, and how to 
manage 
complications 
oncologists & 
reviewed by IRB 
2.  Fee-
Schroeder et 
al. (2013) 
Quasi-
experimental 
Level III 
Quality C 
 
Instructing patients 
on side effect 
manage-ment and 
behavioral 
strategies can 
decrease health-
related distress, 
increase coping, 
reduce anxiety, and 
promote self-care  
n = 81 
66 patients 
and 15 care 
givers  
Evidence-based 
chemotherapy curriculum 
focused on:  self-care 
strategies for side effects  
11 min DVD was created 
utilized experts from Mayo 
Clinic were involved & 
utilized with a nurse led 
group discussion 
 
Post class study 
immediately following  
And n = 42 completed an 8 
week follow up survey  
 
SPSS was used to 
summarize data 
Descriptive statistics  
(mean, SD) 
 
  
65 patients (98%) 
had increased self-
reported 
understanding of 
side effects 
98% had increased 
motivation to use 
self-care strategies  
100% confidence to 
manage side effects 
S:  
n = 31 47% found 
benefit in the class 
even though they 
had started chemo  
DVD was 
inexpensive to 
create  
W:  
No statistics 
provided  
31 patients had 
already begun 
chemo prior to 
attending class  
No convenience 
sample  
Class was open to 
anyone who chose, 
size varied from 
session to session 
Survey not 
validated  
NURSE-DELIVERED STANDARDIZED CHEMOTHERAPY 41 
 
3.  Gallegos et 
al. (2019) 
 
Quasi-
experimental 
Level III 
Quality C 
Standard-ization of  
chemo-theapy 
education 
improved nurse 
and patient 
satisfaction 
n = 80 
patients pre-
intervention 
n = 84 post 
intervention 
n = 30 
nurses pre 
n = 25 post 
Questionnaires given to 
patient cycle 1 day 1 of 
new treatment 
Nursing education staff 
given pre- and post-
intervention questionnaires 
education: pre-
chemotherapy checklist for 
team, group led education 
class, written material, 
short video, template in 
EMR to document  
SAS used for 
descriptive statistics 
p < 0.05 
t-test and ANOVA  
nursing staff 
increased 
satisfaction, overall 
26.5%      (p < 
0.001) 
 
patient satisfaction 
scores unchanged, 
high pre- and post 
women had high 
post satisfaction 
scores regarding 
resources for side 
effect management 
(4.4 vs. 4.1; p = 
0.02) 
 
 
S:  standardized 
education improved 
nursing satisfaction 
related to education 
W:  
small study size, 
patient satisfaction 
scores markedly 
high pre- and post 
tool used not 
specific to side 
effect questions 
This institution also 
already has a nurse 
navigator to provide 
information 
 
4.  Garcia 
(2014) 
Integrative 
Review  
Level IV  
Quality C 
Question: what is 
the most effective 
interven-tions for 
anxiety in patients 
beginning chemo-
therapy? 
n = 10 
articles 
Literature search of 
CINAHL, MEDLINE, 
ProQuest, Joanna Briggs 
Institute Clinical Online 
Network for Evidence of 
Care and Therapeutics, 
Cochrane Collaboration 
and Library and National 
Guidelines Clearinghouse  
 
n/a 9 studies = patient 
education is 
effective in 
decreasing anxiety 
Specifically – 
information about 
treatment, side 
effect management, 
orientation to 
infusion room 
setting 
Best done prior to 
initiating chemo  
Written and verbal 
instruction allows 
S:  
Methods clearly 
described 
Evidence appraisal 
methods explained 
Implications for 
nursing: RNs are 
appropriate 
healthcare providers 
to lead educational 
sessions 
W:  
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pts to continue 
learning after initial  
 
studies are older 
than 5 years, though 
still relevant   
 
 
5.  Keener 
(2018) 
Quasi-
experimental 
Level III 
Quality C 
What effect does 
digitally recorded 
stand-ardized, pre-
chemotherapy 
teaching methods 
have on knowledge 
recall in patients 
receiving first 
chemo? 
What effect on 
post-treatment 
anxiety? 
n = 92 
control  
 n = 5 
tradition.  
digital 
English  n = 
75 
 digital 
Spanish  n = 
12  
 
 
 
Pretest/posttest design 
Intervention group 
received digitally recorded 
education of 9-minute 
recorded presentation 
(Common side effects, 
treatment plans, tips for 
home care, lifestyle 
changes, chemo admin, 
what to expect during 
infusion, team overview, 
discharge instructions) 
 
Standard group = 
traditional lecture-based 
education 
Both groups 
question/answer time and 
written material  
SPSS used 
inferential and 
descriptive statistics 
 
paired-sample t tests 
 
Anxiety scores 
lower education for 
all groups 
Significant decrease 
in tense/being 
worried  
(p < 0.001) 
All groups 
knowledge recall 
improved  
 
 
 
S:  
Two types of 
education analyzed 
Digitally recorded 
video can be 
beneficial for 
patients and time 
efficient for nursing 
Low cost and 
effective method 
W:  
Survey not tested 
for reliability or 
validity 
 
Small sample size  
Tool used very brief 
6.  Neuss et al. 
(2017) 
ASCO 
guidelines  
Agree II score 
67 
Purpose to update 
ASCO/ONS 
chemo-therapy 
Admin-istration 
Safety Standards  
Adults and 
pediatric 
cancer 
patients  
Updated in 2011 and 
revised 2013 
Joint workshop with 
stakeholders on 5/12/2015 
Extensive literature search 
included 97 articles for this 
update 
n/a Education prior to 
first chemo should 
include the 
minimum  
Contain both verbal 
& written 
information  
Diagnosis  
S: 
Industry guideline 
recommend-ations 
Recently updated   
NURSE-DELIVERED STANDARDIZED CHEMOTHERAPY 43 
 
Expert panel  
Public content  
Goals of tx, 
duration, schedule, 
supportive 
medications, 
adverse effects, 
symptoms, follow 
up plans  
Should include 
family  
7.  Milanti 
(2016) 
Quasi-
experimental  
Level III 
Quality B 
Psyco-educational 
therapy integrates 
psyco-therapeutic 
and educational 
interventions can 
address 
psychological 
distress of breast 
cancer and cervical 
cancer patients  
n = 100 
50 interven-
tion group  
50 control 
group  
Pretest/posttest design 
Comparison group not 
treated with intervention 
but standard care 
42-minute psycho-
educational video while 
receiving chemo (3 parts: 
positive reappraisal, 
education, and relaxation) 
 
The education portion of 
the video included info on 
chemo, symptom 
management, physical and 
psychological symptoms 
(info summarized from 
ASCO, NCCN, and ONS) 
Distress thermometer was 
used  
SPSS was used for 
data analysis  
Mann-Whitney U 
test 
Distress mean 
before the 
intervention 3.9 
(95% CI: 3.41-4.43) 
and median 4.0 SD 
2.58 
In the intervention 
group the distress 
level decreased 
(p=0.0001) 
64% had less 
clinically significant 
distress after the 
intervention  
 
S:   
One intervention 
was used 
W: 
Do not know what 
kind of education 
the control group 
had? what is usual 
care  
Non-probability 
sampling methods  
Small size  
Short period of time 
between 
intervention and 
post intervention 
data collection  
 
 
8.  Mollaoglu 
(2014) 
Planned education 
can decrease side 
effects of chemo 
and improve QOL 
n = 120 
60 control 
C-SAS 
Control group received 3 
education sessions:  
Median Mann-
Whitney U test and 
Wilcoxon signed 
rank test  
Statistically 
significant (p < 
0.05) decrease in 
frequency of: 
S:  
Utilized both verbal 
in person session 
that include patient 
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Quasi-
experimental 
Level II 
Quality B 
60 exp. Education = verbal session 
and 18-page booklet given 
with session #1  
#1 before 1st chemo (40-45 
min session) 
#2 prior to 2nd chemo (30-
40 min session) 
#3 before 3rd chemo (no 
time given) 
C-SAS repeated after 3rd 
chemo 
SPSS used to assess 
data  
Nausea, vomiting, 
constipation, pain, 
infection signs, 
problems of mouth 
and throat, problems 
of skin and nails, 
appetite changes, 
weight loss/gain, 
feeling 
distressed/anxious, 
feeling pessimistic 
and unhappy, 
unusual fatigue, & 
difficulty sleeping  
statistically 
significant 
decreases in 
severity of eleven 
symptoms and 
discomfort level of 
nine symptoms  
& family with a 
handwritten booklet  
 
W: 
Not-randomized  
3 teaching sessions 
time consuming  
Intervention not 
checked after first 
chemo  
9.  
Papadopoulou
et al.(2017) 
Longitudinal 
study  
Level III  
Quality B 
How is self-
efficacy charact-
erized through out 
chemo?  
Is self-efficacy a 
predictor of lower 
anxiety? 
Is self-efficacy a 
predictor of 
improved QOL 
during chemo? 
Patients to 
receive 
chemo-
therapy 
n = 135 
Anxiety was measured 
prior to first chemo and at 
the start of each subsequent 
6 cycles 
STAI- State Trait Anxiety 
Inventory and  
SUPPH Strategies Used by 
People to Promote Health 
Descriptive statistics  
SPSS used 
Longitud-inal 
relationship 
between HRQOL 
and self-efficacy 
scores 
Bonferroni adjusted 
sig level alpha 
0.05/20 = 0.003 
Significant 
relationship 
between self-
efficacy (p < 0.05) 
and state anxiety at 
all time points 
Significant (p < 
0.05) relationship 
between self-
efficacy and 
HRQOL scores.   
Higher self-efficacy 
associated with 
increases in 
functioning 
(physical, emotions, 
S:   
Findings support 
empowering of 
patients to less 
stress during chemo 
– enhanced by 
education 
Specifically 
mentions use of 
audio-visual 
education 
W:  
Not specifically 
looking at education  
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and functional) and 
lead to fewer cancer 
related issues during 
chemo (p = 0.0001). 
 
  
 
 
10.  Sahin 
(2015) 
Quasi-
experimental  
Level II 
Quality B 
 
 
Nurse education 
planned model will 
improve quality of 
life and adherence 
to treatment  
n = 140  
70 trial 
70 control 
 
Measure education  
Secondary aim=describe 
symptoms 
Chemotherapy symptom 
assessment scale (CSAS) 
About to receive chemo 1st 
time:  
<Prior to education 
educational needs were 
personalized> 
1st session:  verbal 
information given to 
patient + family 60-65 min 
Booklet provided after the 
session  
2nd session prior to 2nd 
chemo 30-45 min 
3rd session prior to 3rd 
chemo 
 
CSAS completed 10 days 
after the 3rd chemo  
SPSS software used 
for data analysis 
Mann-Whitney U, 
paired samples t, chi-
square, Cronbach’s 
alpha test 
Statistically 
significant changes 
(p < 0.05)  
Nausea and 
vomiting, 
distressed/anxious, 
feeling 
pessimistic/unhappy
, feeling unusually 
tired and difficulty 
sleeping less 
common in 
experimental group 
Severity of 
symptoms 
Nausea/vomiting, 
distress/anxious, 
feeling 
pessimistic/unhappy
, feeling, unusually 
tired, and difficulty 
sleeping less 
common 
Degree of 
discomfort 
nausea/vomiting, 
distressed/anxious, 
feeling pessimistic 
unhappy, feeling 
S:   
Used verbal 
teaching and a 
booklet  
 
W:   
3 education session 
time consuming 
Intervention not 
checked after first 
session before 2nd 
chemo  
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usually tired, and 
difficulty sleeping 
were lower  
11.  Sahin 
(2016) 
Quasi-
experimental  
Level II 
Quality B 
Patients can 
manage treatment 
related symptoms 
through 
educational 
interventions to 
improve outcomes 
such as QOL and 
health status  
n = 120  
60 exp.  
60 control  
All with 
stages I-III 
breast 
cancer  
Educational intervention 
conducted prior to first 
cycle 
Pre-test & post test 
Verbal education session 
50-55 minutes 
Booklet provided at the 
end of session 
2nd session prior to 2nd 
cycle 35-45 minutes 
3rd session prior to 3rd cycle 
– patients and family  
CSAS completed 10 days 
after 3rd chemo and QOL 
index  
SPSS used to 
analyze data 
 
Statistically 
significant (p < 0.05) 
 
X2 test or Fisher 
exact test  
Mann-Whitney U 
test 
Paired t test  
 
CSAS and Quality of 
Life Index-Cancer 
Version  
Symptoms 
distress/anxiety, 
feeling 
pessimistic/unhappy
, feeling unusual 
tired, and difficulty 
sleeping less 
common in posttest 
experimental group  
(p < 0.05) 
Degree of 
discomfort 
distress/anxiety, 
feeling 
pessimistic/unhappy
, and difficulty 
sleeping lower in 
posttest exp group  
(p < 0.05) 
Conclusion patients 
in the intervention 
group had higher 
overall QOL  
S:  
Booklet details: 
pharm/non-pharm 
info on chemo, 
common adverse 
effects 
Only used 1 
interventional 
session  
W:   
Sample only breast 
cancer patients  
12.  Yuce 
(2017) 
Randomized 
controlled 
study  
Level I 
Quality B 
Does education 
have an effect on 
prevention of oral 
mucositis and 
improve QOL? 
n = 60 
30 educ. 
group  
30 control 
group 
Instruments used;  
Scale for Assessing 
Quality of Life in Cancer 
Patients  
and  
Oral Assessment Guide 
Chi-square analysis, 
Mann-Whitney U 
Test, number, 
percentage, mean, 
standard deviation, 
median  
p < 0.05 
Statistically 
significant 
difference between 
education group and 
control group on 
degree of mucositis 
(days 5, 10, 15 & 
21) 
S:   
Oral mucositis 
common among 
some chemo. (37%) 
Randomized 
controlled trial 
W:  
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Patient education booklet 
created by researchers 
(nutritional 
recommendations, 
recommendations for 
dryness, recommendations 
on issues of taste, smell 
changes, use of oral 
hygiene) 
Routine nursing 
recommendations in 
another group  
Oral Assessment Guide 
days 5, 10, 15, 21  
Statistically 
significant 
difference education 
group and control 
group experiencing 
reduced saliva (5th 
day) 
Difficulty 
swallowing (5th day) 
Deterioration of 
taste (5th day) 
Avg. functional 
scores (QOL) 
significant 
difference (p = 
0.017) 
Small study size 
Focused on 
education and 
outcomes of one 
specific side effect 
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Phone Numbers 
 
Main Number      (352)555-1212 
 Includes after hours and weekends 
Nurse Triage Line  
 Includes medication refills   (352)555-1213 
Billing Questions      (352)555-1214 
Appointment Questions    (352)555-1215 
Pharmacy       (800)123-4567 
 
Website  
For support, clinical trial, care management info:  Flcancer.com 
 
After Hours Calls 
After hours will reach answering service.   
Your call will be returned by either the physician or nurse practitioner or PA 
on call.  
Provide the following:  
1.  your diagnosis 
2.  chemotherapy you are receiving 
3.  date of your last chemo 
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Preparing for Chemotherapy 
 
Frequently asked questions 
 
Q:  When should I arrive for my appointment? 
A:  Please arrive at your scheduled time.  Arriving earlier does not mean 
you will be seen earlier  
 
Q:  What should I bring to occupy my time? 
A:  You may bring:  tablets, books, newspapers, magazines or any reading 
material.  Please use headphones or ear buds so as not to disturb other 
patients.  ALL CELLPHONES SHOULD HAVE RINGER SILENCED 
 
Q:  Can I bring food or drinks? 
A:  We provide light snacks (peanut butter crackers & cookies), juice, 
water, and ginger ale.  You may bring other drinks & snacks with you. 
 
Q:  Can I bring a blanket or pillow? 
A:  We will provide you warm blankets and have a pillow.  If you prefer you 
may bring your own from home.  The treatment room is kept at 70° F. 
 
Q:  Should I take my regular medications before coming? 
A:  Unless otherwise advised by your oncologist you may take all your 
home medications 
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Q:  What is an infusion reaction? 
A:  Symptoms of a reaction include:  itching, rash, hives, chills, headache, 
muscle pains, dizziness, sweating, nausea/vomiting, cough, shortness of 
breath, chest tightness, increase or decrease blood pressure, increase 
heart rate, feeling like throat is closing, numbness of extremity or tongue.  
LET YOUR NURSE KNOW IMMEDIATELY.   
 
Q:  Can I bring friends or family with me? 
A:  Every patient can bring one family member/friend with them to the 
treatment room.  However, if space is limited and the chair is needed for a 
patient, we will ask the family/friend to return to the waiting room until a 
chair is available.  
 
Q:  What is the WIFI information? 
A:  Network:  FCSguest 
      Password:  fcsnet08 
 
Other common questions to ask:  
Will I lose my hair? ____________________________________________ 
Is there any medications I should 
avoid?______________________________________________________
____________________________________________________________
____________________________________________________________ 
Can I swim in a pool?__________________________________________ 
Can I exercise?_______________________________________________ 
Do I need to wear a mask or gloves?______________________________ 
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When to contact the office & urgent calls:  
• Chest pain – Call 9-1-1 
• Fever – temperature more than 100.5 
• Excessive shaking or chills  
• Uncontrolled vomiting – more than 4 times in 24 hours 
• Bruising or bleeding 
• Dizziness or light-headed 
• Blood in urine or stools 
• Severe constipation (no bowel movement for 3 days) or diarrhea not 
managed by over the counter anti-diarrheal medication 
• Urinary pain, frequent urination, inability to urinate  
• Extreme fatigue (example – unable to perform regular Activities of 
Daily Living such as fixing a meal, getting dressed, using the 
restroom)  
• New pain location  
• Headache not relieved by ibuprofen or acetaminophen  
• Mouth sores  
• Unable to eat or drink 
• A brand-new symptom 
• Rash 
 
Internet Resources 
American Society of Clinical Oncology (ASCO) patient resources – 
www.Cancer.net 
Chemotherapy and side effects, Cleveland Clinic – www.Chemocare.com 
American Cancer Society – www.Cancer.org 
National Comprehensive Cancer Network (NCCN) patient resources 
www.NCCN.org 
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Your Treatment Plan 
 
Cancer type/location/histologic 
type:________________________________________________________
___________________________________________________________ 
Treatment goal:_____________________________________________ 
Chemotherapy:_______________________________________________
____________________________________________________________
___________________________________________________________ 
 
Time expected per treatment: 
1st treatment: __________________________________________ 
Consecutive treatments: _________________________________ 
Frequency: __________________________________________ 
 
Medications to take at home before treatment:  
(Ex: if you treatment includes Alimta or Taxotere you should be prescribed 
dexamethasone the day before and after chemo) 
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
Prescriptions given:  
____________________________________________________________
____________________________________________________________
____________________________________________________________
___________________________________________________________ 
(6) 
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Port Information 
What is a port? 
Device implanted under the skin by a surgeon or radiologist  
Small disc shape – quarter sized 
Can be used to draw blood  
Can be used for chemotherapy and other medications  
 
Care of port 
Will be flushed each treatment 
Flushed every 4-8 weeks when not in use 
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Understanding Your Blood Count 
 
3 Main types of blood cells:  
 
Name Normal Ranges 
Red Blood Cells (RBC)  
Hemoglobin (Hgb) 12-16 
Hematocrit (HCT) 37-47% 
White Blood Cells (WBC) 4.2-10 
Absolute Neutrophil Count (ANC) 1.5-6.5 
Platelets 140-440 
 
 
Common terms:  
Anemia – Low Red Blood Cells 
Neutropenia - Low White Blood Cells 
Thrombocytopenia – Low Platelets  
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Side Effect Management of Symptoms 
 
Fatigue:  
• Space out activities and use rest periods 
• Good nutrition 
• Stay hydrated – drink 8-10 glasses fluids daily (decaffeinated drinks) 
• Engage in light to moderate activity daily such as walking 
• Rest when needed 
 
Hair Loss Due to Chemotherapy 
• Will vary depending on type of chemotherapy  
• Will start to fall out around 14 days after first chemotherapy 
• May choose to cut hair short 
• Eyelashes and eyebrows may fall out 
• May cause scalp tenderness 
• Plan to shop for a wig before you start treatment if possible 
• May grow back different texture or color 
Anemia – Low Red Blood Cells 
• Symptoms may include:  fatigue, shortness of breath, dizziness, 
lightheadedness, fast heart beat 
• Things you can do:  Get up slowly, rest often when needed 
• Good nutrition 
•  
Thrombocytopenia – Low Platelets 
• Platelets help blood to clot 
• When low at risk for bleeding 
• Signs of low platelets:  easy bruising, small pinpoint red spots on 
skin, blood in urine, blood in stools (black stools), bleeding from gums 
or nose 
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• Things you can do to prevent injury:  use a soft bristle toothbrush, 
blow nose gently, use an electric razor, avoid contact sports, avoid 
using enemas, rectal suppositories, keep stools soft 
• If injury or bleeding apply pressure to area 
 
Neutropenia – Low White Blood Cells  
• White blood cells fight infection 
• Signs of infection include:  temperature greater than 100.5 F, chills, 
sweats, cough, coughing up secretions, mouth sores or white patches 
in mouth or tongue, burning/pain with urination, redness or pain and 
swelling of skin, pus or drainage 
• May require injections to stimulate growth of white blood cells or an 
on-body injector may be placed on you after your chemo 
 
How to Reduce Risk of Infection:  
• Avoid those with colds or illness 
• Consult with physician before getting any vaccinations or dental work 
• Avoid large crowds if possible 
• Wash hands frequently 
• Brush teeth and good oral care 
• Wash fresh fruits and vegetables 
• Wear gloves when cleaning animal cages, fish tanks, cat litter, yard 
work 
 
Mouth Sores  
• Use a soft bristled toothbrush and replace regularly 
• Avoid spicy or acidic foods 
• Avoid mouthwash that contains alcohol 
• May rinse with salt and baking soda after meals and at bedtime (1 
cup warm water, ¼ tsp. baking soda, 1/8 tsp. salt) – Rinse & spit 
• Remove and clean dentures well 
• Use lip balm and keep mouth and lips moist 
• Sip water or ice chips 
(10) 
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Taste Changes/Changes in Appetite 
• Eat frequent small meals (5 or 6 small meals instead of 3 large 
meals) 
• Choose foods high in calories and protein 
• If food has metallic taste, try plastic utensils 
• Eat with friends/family 
• Drink soups or milkshakes that are easy to swallow 
• Food diary:  Write down how much you eat and drink each day  
Nausea & Vomiting  
• Eat small frequent meals for 24-48 hours after chemotherapy 
• Avoid spicy, fried, or fatty foods. 
• Avoid alcohol or acidic foods (orange, grapefruit, tomato) 
• Suck on ice chips or popsicles 
• Do not lie down right after eating 
• Take prescribed medications for nausea  
• May also use:  Maalox, Mylanta, or TUMS for upset 
stomach/indigestion 
• Wait 40-60 minutes after taking nausea medications before eating 
Diarrhea 
• 4 or more loose watery stools in 1 day 
• Drink 8-10 glasses of liquids daily (water, ginger ale, Gatorade, 
decaffeinated tea, broth, jello) 
• Use loperamide 4mg followed by 2mg every 4 hours:  MAX 8 tabs in 
1 day 
• Follow the BRAT diet:  bananas, rice, apple sauce, tea/toast 
• Foods that may worsen diarrhea:  Milk products, greasy/spicy foods, 
caffeine, chocolate 
• Herbs/supplements that may worsen diarrhea:  magnesium, fish oil, 
cat’s claw, garlic, flaxseed, high dose Vit C, aloe 
• call office if diarrhea does not resolve in 24 hours  
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Constipation 
• Decrease in number of stools, hard or dry stools, straining 
• Increase foods with fiber (vegetables, fruits, bran, raisins, whole grain 
cereals) 
• Add prunes or prune juice to diet 
• Drink at LEAST 8 glasses water daily 
• Increase exercise such as walking 
• If no bowel movement in 2 days:  Use a stool softener docusate 
sodium (100-300mg/day) and Senna (2-6 tablets twice daily) increase 
or decrease until you have a good bowel movement every 1-2 days.  
• If bowels become loose stop the pills until more firm and start again 
at lower dose 
• May also take Milk of Magnesia 2-4 tsp. at bedtime 
Pain  
• Treatment may include Tylenol, Ibuprofen (if not contraindicated by 
other conditions, check with your provider) 
• Other prescription medications 
 
Peripheral Neuropathy 
• Pain due to irritation of nerve endings in hands or feet 
• Burning, numbness, tingling or loss of coordination 
• Avoid extreme temperatures 
• If you are receiving oxaliplatin avoid cold temperatures or objects 
for 5-7 days after treatment, may need to wear gloves to reach inside 
refrigerator, drink room temperature or warm liquids 
• Don’t drink alcohol 
• Physical therapy may help with balance  
• May need prescription medications – ask your physician 
• Non-drug treatments:  massage, physical therapy, acupuncture or 
relaxation 
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Hand-Foot Syndrome 
• Known as palmar-plantar erythrodysesthesia 
• Caused by some types of chemotherapy 
• Signs include: Tingling, burning, redness, flaking, peeling, swelling, 
rash, small sores or blisters, cracking 
• Affects palms of hands and soles of feet 
• Call physician or nurse 
• Avoid direct sunlight or wear sunscreen 
• Shower or baths in lukewarm water 
• Mild soaps  
• Apply mild creams:  Udderly smooth, Bag Balm, Eucerin, Aveeno or 
Lubriderm 
• Apply antibiotic ointment if prescribed  
• May be recommended to take Vitamin B6 100mg three times daily for 
1 week, then 50mg three times daily until treatment is completed  
 
Skin Conditions 
• Skin may become more sensitive 
• Rashes may develop 
• More sensitive to sun 
• Things that may help:  Drink 8-10 glasses water daily, use mild soap 
and lotions, use sunscreen, pat dry instead of rubbing, nail polish 
may strengthen nails, keep nails short 
• Call your doctor or nurse  
 
Skin Conditions When Taking Targeted Therapy (EGFR)  
• Examples of EGFR medications (Erbitux, Vectibix) 
• Rash that may look like acne 
• Red or inflamed skin 
• Dry skin, cracks in skin, or crusting  
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• Skin around nails tender, red and swollen 
• Tips to help: mild soaps (Ivory, Dove, Aveeno), gentle moisturizer 
(Udderly Smooth, Aveeno, Eucerin, Cetophil, Lubriderm), avoid sun 
• Call your physician or nurse 
 
Immune Therapy Common Side Effects  
• Examples of Immune Therapy (Opdivo, Keytruda, Imfinzi) 
• Skin reaction (redness, blistering, dryness) 
• Flu like symptoms (tired, chills, weakness, body aches) 
• Let your doctor or nurse know if you have any of the following:  
a. New or worse cough 
b. shortness of breath or chest pain 
c. yellowing of the skin 
d. severe nausea/vomiting 
e. dark urine 
f. diarrhea 
g. blood in stools, dark stools, tarry stools 
h. unusual headaches, changes in mood, confusion 
i. blisters on skin or ulcers in the mouth 
 
 
Birth Control and Sexuality  
• Temporary or permanent infertility and sexual dysfunction may result 
from chemotherapy 
• Discuss concerns about sexual issues and fertility with your physician 
or nurse  
• Always use a method of birth control 
• Females may use lubrication (Astroglide, Refresh or other non-
hormonal lubricant) for vaginal dryness. 
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Appendix D 
Measurement Tools 
 
 
NCCN Distress Thermometer and Problem List  
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Appendix E 
Theoretical Framework  
 
Mishel’s Theory of Uncertainty in Illness  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
•perception of illness 
•threat vs. 
opportunity 
•strategies
•information 
gathering 
•blocking/avoidance
•stimuli/diagnosis
•expectations
•coping/support 
systems
•new balance 
•new life view
•adjustment
Adaptation 
to the illness
Antecedents 
generating 
uncertainty
Appraisal of 
uncertainty
Coping with 
uncertainty
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Appendix F 
IRB Approval  
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Appendix G 
Patient Satisfaction Survey Tool 
 
Please circle the number that best fits your satisfaction with the education you 
received about your chemotherapy treatment.  
5 is the highest score; 1 is the lowest. 
Did you feel you received enough information before starting your chemo? 
5  4 3 2 1 
Materials provided were easy for you to understand. 
5 4 3 2 1 
Enough time was spent on education. 
5 4 3 2 1 
You felt all your questions were addressed.  
5 4 3 2 1 
Please answer the following Yes or No 
Did you call the triage nurse or come to the office with a concern about your 
treatment? 
Yes No 
Did you visit the Emergency Department, Urgent Care or Hospital for an emergent 
issue regarding your treatment? 
Yes No 
Other comments you would like to share about the educational process: 
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
________________________________Thank you for your participation.  
NURSE-DELIVERED STANDARDIZED CHEMOTHERAPY 68 
 
Appendix H 
Cost Analysis 
 
 Costs of proposal  
1 RN/charge nurse $36/hour 2 hours training $72.00 (one-time 
cost) 
Printing costs $0.42 per page 20 pages (estimate) $8.40 
Estimated 
patients/week 
10 $8.40 $84.00 
Estimated annual 
cost 
  $4368.00 
 
Estimated cost of supportive care for one episode 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cost of Complete 
Blood Count (CBC) 
1 $29.00 
1-hour intravenous 
infusion time 
1 $187.00 
Each additional hour 1 $81.00 
Antiemetic (example 
Zofran) 
8mg x 1 $16.00 
Steroid (example 
Decadron) 
10mg x 1 $10.00 
1-liter normal saline 1 $6.00 
Total cost  $329.00 
